Lowe Brockenbrough & Company Has Decreased Amerisourcebergen Com (ABC) Holding; Last Week MiMedx Group, Inc. (MDXG) Analysts

June 24, 2018 - By Linda Rogers

MiMedx Group, Inc. (NASDAQ:MDXG) Logo

Among 9 analysts covering MiMedx Group (NASDAQ:MDXG), 5 have Buy rating, 2 Sell and 2 Hold. Therefore 56% are positive. MiMedx Group had 30 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, January 18 by Needham. The stock of MiMedx Group, Inc. (NASDAQ:MDXG) has “Buy” rating given on Wednesday, October 14 by Needham. Needham maintained MiMedx Group, Inc. (NASDAQ:MDXG) rating on Tuesday, October 10. Needham has “Buy” rating and $21.0 target. Lake Street downgraded the shares of MDXG in report on Monday, February 26 to “Hold” rating. The stock of MiMedx Group, Inc. (NASDAQ:MDXG) has “Buy” rating given on Friday, December 18 by Canaccord Genuity. Northland Capital upgraded it to “Outperform” rating and $10 target in Friday, October 30 report. The firm has “Buy” rating by Piper Jaffray given on Wednesday, December 13. Aegis Capital initiated the stock with “Buy” rating in Tuesday, November 8 report. On Monday, October 30 the stock rating was maintained by Needham with “Buy”. The firm has “Buy” rating given on Friday, August 18 by Piper Jaffray. See MiMedx Group, Inc. (NASDAQ:MDXG) latest ratings:

26/02/2018 Broker: Lake Street Old Rating: Buy New Rating: Hold Downgrade
23/02/2018 Broker: Craig Hallum Rating: Buy New Target: $19.0
20/02/2018 Broker: Needham Old Rating: Strong Buy New Rating: Hold Downgrade
18/01/2018 Broker: Needham Rating: Buy New Target: $21.0 Maintain
08/01/2018 Broker: Needham Rating: Buy New Target: $21.0 Maintain

Lowe Brockenbrough & Company Inc decreased Amerisourcebergen Corp Com (ABC) stake by 67.53% reported in 2018Q1 SEC filing. Lowe Brockenbrough & Company Inc sold 14,579 shares as Amerisourcebergen Corp Com (ABC)’s stock declined 15.00%. The Lowe Brockenbrough & Company Inc holds 7,009 shares with $604,000 value, down from 21,588 last quarter. Amerisourcebergen Corp Com now has $20.55 billion valuation. The stock increased 0.31% or $0.29 during the last trading session, reaching $93.5. About 1.03M shares traded. AmerisourceBergen Corporation (NYSE:ABC) has declined 6.17% since June 24, 2017 and is downtrending. It has underperformed by 18.74% the S&P500. Some Historical ABC News: 07/03/2018 – FDA head Gottlieb criticizes industry for “Kabuki drug-pricing”; 08/03/2018 – Health insurer Cigna to buy Express Scripts in $67 bln deal; 02/05/2018 – AMERISOURCEBERGEN 2Q REV. $41.0B, EST. $40.59B; 02/05/2018 – AmerisourceBergen Sees FY Adj EPS $6.45-Adj EPS $6.65; 09/03/2018 – The Moyer Foundation Receives Grant from the AmerisourceBergen Foundation to Launch New Community Program for Children Living; 15/05/2018 – Vulcan Adds Facebook, Exits Booking, Cuts AmerisourceBergen: 13F; 02/05/2018 – AmerisourceBergen 2Q Effective Tax Rate 21.9%; 07/03/2018 FDA HEAD GOTTLIEB CRITICIZES U.S. PHARMACEUTICAL PRICING STRUCTURE, CALLS IT “KABUKI” THEATER; 23/05/2018 – AmerisourceBergen Not a Buyout Target as Walgreens Shuns Deals; 08/03/2018 – Kentucky sues drug distributor AmerisourceBergen over opioid epidemic

More recent MiMedx Group, Inc. (NASDAQ:MDXG) news were published by: Globenewswire.com which released: “Bragar Eagel & Squire, PC is Investigating Certain Officers and Directors of MiMedx Group, Inc. (MDXG) and …” on June 23, 2018. Also Seekingalpha.com published the news titled: “MiMedx: Internal Investigation Nears Its End” on June 08, 2018. Benzinga.com‘s news article titled: “MiMedx Audit Results In Restatement Of 5 Years Of Financials” with publication date: June 07, 2018 was also an interesting one.

The stock increased 6.98% or $0.39 during the last trading session, reaching $5.98. About 1.58 million shares traded. MiMedx Group, Inc. (NASDAQ:MDXG) has declined 39.49% since June 24, 2017 and is downtrending. It has underperformed by 52.06% the S&P500. Some Historical MDXG News: 15/03/2018 – RT @AlderLaneeggs: It wouldnt surprise me if $MDXG is raided by the Feds give when @AureliusValue just exposed.. Time to out an end to thi…; 28/03/2018 – MiMedx Enrolls First Patient In Its Phase 2B Clinical Trial Of RMAT Designated AmnioFix® lnjectable For The Treatment Of Osteoarthritis Of The Knee; 15/03/2018 – RT @AlderLaneeggs: Any thoughts on what this fellow is doing in a Garage and who he currently works for ? $MDXG @viceroyresearch @AureliusV…; 18/04/2018 – Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against; 26/03/2018 – MiMedx Group: Patients Experienced Clinically Meaningful Reduction in Pain; 11/04/2018 – Safirstein Metcalf LLP Reminds Investors that Class Actions have been Filed Against MiMedx Group, Inc. — MDXG; 09/03/2018 – MIMEDX: AMNIOFIX GETS RMAT DESIGNATION BY FDA; 16/03/2018 – Citron chimes in on MiMedx. Countdown to formal investigation. $3 price target; 26/03/2018 – MiMedx Group: Statistically Significant Difference in Pain and Function Compared to Placebo; 24/05/2018 – Fantastic that “distinguished” Larry Papasan is on $MDXG audit committee with Pete’s frat brother. Chairman of paid Honig promotion $MDVX left investors with total losses

Investors sentiment decreased to 0.91 in 2018 Q1. Its down 0.10, from 1.01 in 2017Q4. It dropped, as 39 investors sold MiMedx Group, Inc. shares while 61 reduced holdings. 37 funds opened positions while 54 raised stakes. 81.08 million shares or 5.91% less from 86.17 million shares in 2017Q4 were reported. Schwab Charles Inc holds 0% of its portfolio in MiMedx Group, Inc. (NASDAQ:MDXG) for 609,168 shares. Virginia Retirement Sys Et Al reported 0% stake. Oz L P owns 0.01% invested in MiMedx Group, Inc. (NASDAQ:MDXG) for 159,200 shares. Globeflex Cap Limited Partnership has invested 0.11% of its portfolio in MiMedx Group, Inc. (NASDAQ:MDXG). Lourd Limited Liability Co holds 0.03% of its portfolio in MiMedx Group, Inc. (NASDAQ:MDXG) for 32,436 shares. Lazard Asset Management Lc holds 0% in MiMedx Group, Inc. (NASDAQ:MDXG) or 37,803 shares. Aperio Group Ltd Liability Corp invested in 19,899 shares. Moreover, Deutsche State Bank Ag has 0% invested in MiMedx Group, Inc. (NASDAQ:MDXG) for 592,600 shares. 116 were accumulated by Fifth Third National Bank & Trust. Disciplined Growth Investors Mn accumulated 713,706 shares. Financial Bank Of Mellon invested 0% in MiMedx Group, Inc. (NASDAQ:MDXG). Amp Capital Invsts Ltd reported 37,734 shares. Wms Prtn Ltd Com holds 32,604 shares or 0.03% of its portfolio. Millennium Mgmt Ltd Limited Liability Company holds 1.48M shares or 0.01% of its portfolio. Nordea Mgmt holds 0.01% or 459,050 shares.

MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. The company has market cap of $663.99 million. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. It has a 19.23 P/E ratio. The companyÂ’s proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization.

Among 20 analysts covering AmerisourceBergen (NYSE:ABC), 12 have Buy rating, 0 Sell and 8 Hold. Therefore 60% are positive. AmerisourceBergen had 74 analyst reports since July 27, 2015 according to SRatingsIntel. Robert W. Baird maintained AmerisourceBergen Corporation (NYSE:ABC) rating on Wednesday, January 17. Robert W. Baird has “Buy” rating and $112.0 target. The firm has “Buy” rating by Zacks given on Thursday, September 17. As per Friday, May 6, the company rating was maintained by FBR Capital. Cowen & Co maintained the shares of ABC in report on Tuesday, April 3 with “Buy” rating. Credit Suisse maintained the shares of ABC in report on Wednesday, February 7 with “Buy” rating. On Tuesday, October 4 the stock rating was upgraded by Avondale to “Mkt Outperform”. Jefferies maintained it with “Hold” rating and $95.0 target in Wednesday, February 7 report. Needham maintained AmerisourceBergen Corporation (NYSE:ABC) on Friday, September 8 with “Buy” rating. The stock has “Overweight” rating by Morgan Stanley on Thursday, November 10. The stock of AmerisourceBergen Corporation (NYSE:ABC) has “Hold” rating given on Tuesday, August 25 by Zacks.

MiMedx Group, Inc. (NASDAQ:MDXG) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>